Singapore
Lucence raises $20 million Series A for its non-invasive cancer screening technology
Lucence Diagnostics, a genomic medicine startup that develops non-invasive tests for cancer screening, announced today that it has raised a $20 million Series A led
The blockchain hype is over. So it’s the perfect time to invest, says this Singapore VC
[unable to retrieve full-text content]source : techinasia
Alibaba’s Ant Financial may apply for digital banking license in Singapore
[unable to retrieve full-text content]source : techinasia
Healthtech startup Biofourmis, Novartis to launch project in Southeast Asia
[unable to retrieve full-text content]source : techinasia
Singapore online gift card startup bags $845k in seed funding
[unable to retrieve full-text content]source : techinasia
How AI startup QuodAI solves a major headache for software engineers
[unable to retrieve full-text content]source : techinasia
Report shows which e-payment apps Singaporeans use the most
[unable to retrieve full-text content]source : techinasia
This startup helps hotels save on energy costs, thousands of rooms at a time
[unable to retrieve full-text content]source : techinasia
On-demand staffing platform Workmate bags $5.2m in series A round
[unable to retrieve full-text content]source : techinasia
Singapore’s Beenext looks to raise $100m for Emerging Asia fund
[unable to retrieve full-text content]source : techinasia
